Clinical Evaluation of a Recombinant Adeno-Associated Virus (rAAV) Alpha-1 Antitrypsin (AAT) Gene Therapy Vector

被引：0
|
作者：
Chulay, J.
Brantly, M. [1 ]
Wang, L. [2 ]
Mueller, C. [1 ]
Humphries, M. [1 ]
Spencer, L. [1 ]
Rouhani, F. [1 ]
Conlon, T. [1 ]
Spencer, C. [1 ]
Byrne, B. [1 ]
Wilson, J. [2 ]
Flotte, T. [1 ]
机构：
[1] Univ Florida, Gainesville, FL 32611 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2908
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase 2 Clinical Trial Of A Recombinant Adeno-Associated Virus (RAAV) Alpha-1 Antitrypsin (AAT) Gene Therapy Vector
    Flotte, T.
    Trapnell, B.
    Humphries, M.
    Carey, B.
    Calcedo, R.
    Campbell-Thompson, M.
    Rouhani, F.
    Yachnis, A.
    Sandhaus, R. A.
    McElvaney, N. G.
    Brantly, M. L.
    Wilson, J.
    Chulay, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [2] Evaluation of Recombinant Adeno-Associated Virus (rAAV) Alpha-1 Antitrypsin (AAT) Gene Therapy in Mice and Nonhuman Primates
    Chulay, J.
    Knop, D.
    Wang, L.
    Thomas, D.
    Ye, G.
    Kang, W.
    Le Guiner, C.
    Rouhani, F.
    Brantly, M.
    Moullier, P.
    Veres, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [3] Evaluation of Recombinant Adeno-Associated Virus (rAAV) Alpha-1 Antitrypsin (AAT) Gene Therapy in Mice and Nonhuman Primates
    Ye, Guo-Jie
    Kang, Wen
    Wang, Lijun
    Scotti, Marina M.
    Liu, Jilin
    Thomas, Darby L.
    Le Guiner, C.
    Rouhani, F.
    Brantly, Mark
    Knop, David R.
    Moullier, P.
    Chulay, Jeff
    Veres, Gabor
    MOLECULAR THERAPY, 2009, 17 : S317 - S317
  • [4] Toxicology and biodistribution studies of a recombinant adeno-associated virus 2 (rAAV2) alpha-1 antitrypsin (AAT) vector
    Poirier, AE
    Combee, LA
    Martino, AT
    Flotte, TR
    MOLECULAR THERAPY, 2004, 9 : S40 - S40
  • [5] Progress with Recombinant Adeno-Associated Virus Vectors for Gene Therapy of Alpha-1 Antitrypsin Deficiency
    Gruntman, Alisha M.
    Flotte, Terence R.
    HUMAN GENE THERAPY METHODS, 2015, 26 (03) : 77 - 81
  • [6] Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors
    Song, S
    Embury, J
    Laipis, PJ
    Berns, KI
    Crawford, JM
    Flotte, TR
    GENE THERAPY, 2001, 8 (17) : 1299 - 1306
  • [7] Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors
    S Song
    J Embury
    PJ Laipis
    KI Berns
    JM Crawford
    TR Flotte
    Gene Therapy, 2001, 8 : 1299 - 1306
  • [8] Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults
    Flotte, TR
    Brantly, ML
    Spencer, LT
    Byrne, BJ
    Spencer, CT
    Baker, DJ
    Humphries, M
    HUMAN GENE THERAPY, 2004, 15 (01) : 93 - 128
  • [9] Preclinical Evaluation of a Recombinant Adeno-Associated Virus Vector Expressing Human Alpha-1 Antitrypsin Made Using a Recombinant Herpes Simplex Virus Production Method
    Chulay, Jeffrey D.
    Ye, Guo-Jie
    Thomas, Darby L.
    Knop, David R.
    Benson, Janet M.
    Hutt, Julie A.
    Wang, Gensheng
    Humphries, Margaret
    Flotte, Terence R.
    HUMAN GENE THERAPY, 2011, 22 (02) : 155 - 165
  • [10] Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice
    Song, S
    Goudy, K
    Campbell-Thompson, M
    Wasserfall, C
    Scott-Jorgensen, M
    Wang, J
    Tang, Q
    Crawford, JM
    Ellis, TM
    Atkinson, MA
    Flotte, TR
    GENE THERAPY, 2004, 11 (02) : 181 - 186
12345